These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E. Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140 [Abstract] [Full Text] [Related]
15. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients. Ross H, Pflugfelder P, Haddad H, Cantarovich M, White M, Ignaszewski A, Howlett J, Vaillancourt M, Dorent R, Burton JR, CADENCE Study Group. J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227 [Abstract] [Full Text] [Related]
16. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience. Li JT, Danguilan RA, Cabanayan-Casasola CB, Talusan-Tomacruz Y, Ona ET. Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195 [Abstract] [Full Text] [Related]
17. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna. Zuckermann A. J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S206-9; discussion S210-1. PubMed ID: 15774324 [Abstract] [Full Text] [Related]
18. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH. Transplantation; 2010 Apr 15; 89(7):864-72. PubMed ID: 20061999 [Abstract] [Full Text] [Related]
19. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens. Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ. Clin Ther; 2006 Jun 15; 28(6):893-905. PubMed ID: 16860172 [Abstract] [Full Text] [Related]
20. Conversion to everolimus in kidney transplant recipients: a safe and simple procedure. Ruiz JC, Sanchez-Fructuoso A, Rodrigo E, Conesa J, Cotorruelo JG, Gómez-Alamillo C, Calvo N, Barrientos A, Arias M. Transplant Proc; 2006 Oct 15; 38(8):2424-6. PubMed ID: 17097956 [Abstract] [Full Text] [Related] Page: [Next] [New Search]